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Background.  —  Multislice  computed  tomography  coronary  angiography  (MSCT-CA)  is  feasible  in
the emergency  department  (ED)  for  ruling  out  obstructive  coronary  artery  disease  (CAD).
Aim. —  To  investigate  a  diagnostic  strategy  using  MSCT-CA  for  the  early  triage  of  patients  pre-
senting  to  the  ED  with  acute  chest  pain  suggestive  of  acute  coronary  syndrome  (ACS),  according
to the  medium-term  incidence  of  clinical  events.
Abbreviations: ACS, Acute coronary syndrome; BMI, Body mass index; CAD, Coronary artery disease; CI, Conﬁdence interval; ECG,
lectrocardiogram; ED, Emergency department; FFR, Fractional ﬂow reserve; GRACE, Global Registry of Acute Coronary Events; ICA, Inva-
ive coronary angiography; MACE, Major adverse coronary events; MSCT-CA, Multislice computed tomography coronary angiography; mSv,
illisievert; SD, Standard deviation; TIMI, Thrombolysis In Myocardial Infarction.
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disease Methods.  —  We  conducted  a  single-centre,  prospective,  observational  cohort  study  in
123 patients  with  low-risk  to  intermediate-risk  acute  chest  pain  suggestive  of  ACS.  MSCT-CA
was performed  using  dual-source  64-slice  computed  tomography  with  retrospective  electrocar-
diographic  gating.  Patients  without  coronary  artery  lesions  were  discharged  from  the  ED.  The
incidences  of  death,  myocardial  infarction  and  myocardial  revascularization  were  collected
during a  mid-term  follow-up.
Results.  —  According  to  MSCT-CA,  93  patients  (75.6%)  had  no  CAD  or  coronary  artery  stenosis
less or  equal  to  50%  and  28  patients  (22.8%)  had  stenosis  more  or  equal  to  50%.  Invasive  coronary
angiography  was  performed  in  29  patients  (23.6%).  MSCT-CA  accurately  identiﬁed  ten  patients
(8.13%) with  obstructive  CAD  requiring  myocardial  revascularization;  all  had  a  low  TIMI  score
(0—2) and  eight  had  a  low  GRACE  score.  The  mean  estimated  effective  dose  of  MSCT-CA  was
16.3 ±  6.4  mSv.  Median  follow-up  was  15  months.  No  patient  (95%  CI  0—3.0%)  had  major  adverse
cardiovascular  events  during  follow-up.
Conclusion.  —  MSCT-CA  appears  to  be  a  useful  initial  triage  tool  in  the  ED.  When  the  MSCT-
CA result  is  negative,  it  allows  safe  early  discharge  because  of  its  high  negative  predictive
value. In  a  signiﬁcant  number  of  cases  of  low-risk  ACS,  MSCT-CA  detects  severe  coronary  lesions
and allows  further  dedicated  diagnostic  and  therapeutic  intervention.  Reduction  of  radiation
exposure would  help  acceptance  in  clinical  practice.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  — Le  coroscanner  est  un  examen  diagnostique  accessible  dans  les  services  d’urgences
pour éliminer  la  présence  d’une  maladie  coronaire.
Objectifs.  — Nous  avons  étudié  l’intérêt  du  scanner  coronaire  pour  le  triage  précoce  des  patients
se présentant  aux  urgences  avec  un  syndrome  douloureux  thoracique  évocateur  de  syndrome
coronarien  aigu  sans  critère  de  haut  risque,  basé  sur  le  devenir  clinique  à  moyen  terme.
Méthodes. — Nous  avons  réalisé  une  étude  monocentrique  prospective  observationnelle  de
cohorte incluant  123  patients  souffrant  d’un  syndrome  coronarien  aigu  à  risque  bas  ou  inter-
médiaire. Un  scanner  coronaire  a  été  réalisé  à  la  phase  diagnostique  initiale  avec  un  scanner
bi-tube 64  barrettes  avec  synchronisation  rétrospective  à  l’électrocardiogramme.  Les  patients
sans ou  avec  des  lésions  coronaires  minimes  étaient  autorisés  à  quitter  le  service  d’urgence.
Les incidences  des  décès,  infarctus  du  myocarde  et  revascularisation  myocardique  ont  été
prospectivement  collectées  à  un  an.
Résultats.  —  Selon  les  résultats  du  scanner,  93  patients  (75,6  %)  avaient  des  plaques  athéro-
mateuses coronaires  inférieures  ou  égales  à  50  %.  Une  coronarographie  a  été  réalisée  chez
29 patients  (23,6  %).  Le  scanner  coronaire  a  identiﬁé  dix  patients  (8,13  %)  ayant  une  maladie
coronaire obstructive  ayant  justiﬁé  une  revascularisation  myocardique.  Ces  dix  patients  avaient
un score  de  risque  TIMI  bas  entre  0  et  2  et  huit  patients  avaient  un  score  de  GRACE  bas.  La  dose
effective moyenne  du  scanner  coronaire  a  été  de  16,3  ±  6,4  mSv.  Le  suivi  médian  a  été  de
15 mois.  Aucun  patient  (IC  95  %  0—3,0  %)  n’a  eu  d’événement  cardiovasculaire  majeur  durant  le
suivi prospectif.
Conclusions.  —  Le  scanner  coronaire  apparaît  être  un  outil  diagnostique  initial  utile  dans  les
services d’urgences.  Un  scanner  coronaire  négatif  autorise  un  départ  rapide  et  sûr  du  patient
du fait  de  la  forte  valeur  prédictive  négative.  Toutefois,  dans  8,13  %  de  syndrome  douloureux
thoracique  à  risque  bas  ou  intermédiaire,  le  scanner  détecte  une  maladie  coronaire  obstructive
et permet  une  stratégie  diagnostique  et  thérapeutique  complémentaire  spéciﬁque.  La  réduction
de l’irradiation  par  le  scanner  est  nécessaire  avant  l’acceptation  de  cet  examen  dans  la  pratique
quotidienne.
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Background
The  investigation  of  patients  presenting  to  emergency
departments  (EDs)  with  chest  pain  remains  challenging
worldwide  [1—3]. Evaluation  strategies  include  detailed
clinical  assessment,  serum  cardiac  biomarkers,  resting
electrocardiogram  (ECG)  and  individual  determination  of
mortality  risk  [1—3]. This  approach  lacks  diagnostic  accuracy
(
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n low-risk  patients  and  up  to  8%  of  cases  of  acute  coronary
yndrome  (ACS)  are  missed  in  the  ED,  with  a  higher  mortality
isk  [2,4,5].
Multislice  computed  tomography  coronary  angiography
MSCT-CA)  is  accurate  compared  with  invasive  coronary
ngiography  (ICA)  and  is  feasible  and  practical  in  the  ED
6—11].  MSCT-CA  has  a  high  ability  to  rule  out  obstruc-
ive  coronary  artery  disease  (CAD)  [12,13].  Since  2008,
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SCT-CA  has  become  part  of  the  management  strategy  for
ome  patients  with  ACS  without  high-risk  features  in  our
nstitution,  in  agreement  with  American  and  French  recom-
endations  [14,15].  However,  the  relevance  of  this  strategy
s  still  controversial  [16], even  in  our  institution.  The  paucity
f  data  on  the  incremental  value  of  further  diagnostic  tests
nd  on  the  prognosis  of  patients  released  from  the  ED  after  a
ormal  MSCT-CA  explains  why  it  is  difﬁcult  for  health  insti-
utes  to  develop  guideline  recommendations  with  a  great
evel  of  evidence  [3,16].
Therefore,  we  assessed  a  diagnostic  strategy  using  MSCT-
A  for  the  early  triage  of  patients  presenting  to  ED  with
cute  chest  pain  suggestive  of  ACS,  according  to  the
edium-term  incidence  of  clinical  events.
ethods
opulation
e  conducted  a  single-centre,  prospective,  observational
ohort  study  in  low-risk  to  intermediate-risk  ACS  patients.
rom  April  2008  to  September  2009,  123  patients  presenting
o  the  ED  of  the  University  Hospital  of  Rangueil  in  Toulouse,
rance,  were  prospectively  enrolled.  Patients  presenting  to
his  ED  with  acute  chest  pain  or  other  recent-onset  angina-
ike  symptoms,  an  ECG  without  myocardial  ischemia-related
bnormalities  and  without  elevation  of  cardiac  troponin
ould  be  prospectively  enrolled.  Standard  chest  pain  assess-
ent  by  the  ED  physicians  included:
detailed  assessment  of  clinical  history;
CAD  risk  factors;  description  of  symptoms;
physical  examination;
18-lead  ECG;  chest  X-ray;
and  measurement  of  cardiac  biomarkers  (troponin  I),
repeated  six  hours  later.
Patients  could  be  enrolled  at  the  ED  if  their  Global  Reg-
stry  of  Acute  Coronary  Events  (GRACE)  risk  score  was  less
han  119  (http://www.outcomes-unmassmed.org/grace).
Patients  were  excluded  if  aortic  dissection  or  pulmonary
mbolism  was  particularly  suspected;  in  these  cases,  a
tandard  dedicated  diagnostic  algorithm  was  performed.
atients  were  also  excluded  if  there  was  evidence  for  a  cause
f  chest  pain  other  than  myocardial  ischemia.  Patients  were
xcluded  if  the  chest  pain  was  related  to  a  high-risk  ACS.
igh-risk  criteria  were:
ST-segment  elevation  acute  myocardial  infarction;
diabetes  mellitus  known  for  more  than  10  years;
a  rise  in  serum  cardiac  troponin  concentration;
ECG  changes  suggesting  ischemia;
GRACE  risk  score  greater  or  equal  to  119;
history  of  CAD;  and  acute  heart  failure.
These  patients  were  admitted  to  the  cardiology  inten-
ive  care  unit  and  ICA  was  performed  according  to  European
ecommendations  [1].
After  this  evaluation,  the  ED  physician  was  free  to  include
he  patient  in  the  study  if  further  immediate  coronary  eval-
ation  was  considered  as  being  required.  If  the  patient  had
o  CAD  risk  factor,  atypical  chest  pain  and  a  very  low  GRACE
core,  the  ED  physician  could  allow  patient  to  leave  the  ED
ith  an  appointment  to  see  a  cardiologist  a  few  days  later.
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he  safety  and  efﬁciency  of  an  immediate  MSCT-CA  has  not
et  been  demonstrated  in  such  cases.
At  this  stage,  patients  were  not  included  if  MSCT-CA  was
ot  feasible  or  was  contraindicated  because  of:  age  less  than
8  years;  allergy  to  contrast  agents;  pregnancy;  atrial  ﬁbril-
ation  or  frequent  ectopy;  uncontrolled  heart  rate;  inability
o  perform  a  20-second  breath  hold;  body  mass  index  (BMI)
reater  than  40;  or  renal  failure  (creatinine  clearance  less
han  60  mL/min/m2).  If  the  patient  was  suitable  for  inclu-
ion,  a  cardiologist  was  called  to  provide  a  full  explanation
f  the  strategy.  The  patient  was  then  included  if  they  gave
nformed  consent.  Clinical  history,  CAD  risk  factors  and
escription  of  symptoms  were  checked  by  a  cardiologist  at
he  ED.  Thrombolysis  In  Myocardial  Infarction  (TIMI)  [17]  and
RACE  risk  scores  were  calculated.
echnique and image reconstruction
SCT-CA  was  performed  using  dual-source  64-slice  com-
uted  tomography  (SOMATOM,  Dual-Source  Deﬁnition;
iemens  Medical  Solutions,  Erlangen,  Germany)  with  ret-
ospective  electrocardiographic  gating.  Before  acquisition,
he  patients  received  beta-blockers,  targeting  a  heart  rate
ess  or  equal  to  65  beats/min.  The  acquisition  started  at  the
evel  of  the  carina  and  stopped  below  the  heart  after  injec-
ion  of  iodine  contrast.  Calcium  scoring  was  not  studied  (i.e.
nly  one  acquisition  was  performed).  Moreover,  no  delayed
cquisition  was  performed  in  order  to  limit  radiation  expo-
ure.  The  acquisition  delay  was  computed  automatically  by
lacing  a  region  of  interest  in  the  ascending  aorta,  with  a
tart  threshold  of  150  Hounsﬁeld  units.  A  biphasic  injection
sing  a  dual-head  injector  consisted  of  a  bolus  of  1.5  cc/kg  of
ontrast  agent  (iomeprol)  at  a  concentration  of  400  mg/mL
Iomeron  400,  Bracco-Byk,  Milan,  Italy)  followed  by  a  saline
ush.  Collimation  was  64  ×  0.6  mm  with  a  gantry  rotation  of
30  ms  and  a  pitch  of  0.36.  The  reference  tube  current  was
20  mA.  The  tube  voltage  was  adjusted  to  the  patient’s  body
eight:  80  kV  for  patients  less  than  70  kg,  100  kV  for  patients
eighing  70—90  kg  and  120  kV  for  patients  above  90  kg.  Raw
ata  were  reconstructed  with  a  slice  thickness  of  0.75  mm
very  0.5  mm  using  a  standard  kernel,  every  10%  of  the  R-
 interval.  Current  intensity  modulation  was  systematically
pplied  to  reduce  radiation  during  systolic  phases  (maximal
urrent  intensity  between  30—40%  and  70—80%,  depending
n  the  heart  rate).  The  tube  modulation  programme  CARE
ose  4D  was  also  used  (Siemens  Medical  Solutions,  Erlangen,
ermany).
For  each  patient,  the  images  were  uploaded  to  a  dedi-
ated  workstation  (Leonardo;  Siemens,  Erlangen,  Germany)
nd  interpreted  by  two  experienced  cardiac  radiologists  who
ere  aware  of  the  clinical  data.  One,  two  or  three  phases
ere  kept  for  the  analysis,  depending  on  the  heart  rate  of
he  patient  and  the  presence  of  motion  artifacts.  Multipla-
ar  reconstruction,  curvilinear  multiplanar  reconstruction,
olume  rendering  technique  and  maximum  intensity  pro-
ection  were  used  for  the  analysis  (Circulation  Software;
iemens,  Erlangen,  Germany).  A  17-segment  model  of  the
oronary  arteries  and  a  three-point  grading  score  (normal,
ild  [<  50%  luminal  diameter  narrowing],  stenosis  [≥  50%])
ere  used  to  evaluate  coronary  stenosis;  however,  only
egments  greater  than  1.5  mm  in  diameter  were  analysed.
atients  were  classiﬁed  according  to  the  maximal  lesion.
o
b
m
9
t
b
c
s
d
C
R
A
S
l
I
b
t
a
f
c
m
A
o
e
c
n
t
c
g
p
s
a
p
1
n
h
i
ﬁ
t
a
s
a
t
c
e
w
o
1
h
(
o
w
hEarly  triage  of  ACS  patients:  64-slice  CTA  
MSCT-CA  was  considered  as  ‘negative’  when  there  was  no  or
mild  CAD.  MSCT-CA  was  considered  as  ‘positive’  when  there
was  at  least  a  single  coronary  artery  stenosis  greater  or  equal
to  50%.  MSCT-CA  was  also  considered  as  ‘positive’  when  it
was  not  interpretable.
Diagnostic pathway
The  diagnostic  pathway  of  the  patient  according  to  the
MSCT-CA  result  is  summarized  in  Fig.  1.  Patients  without
CAD  or  with  mild  lesions  on  MSCT-CA  were  discharged  early
from  the  ED  without  treatment  after  other  possible  causes
of  chest  pain  had  been  investigated.  All  patients  with  steno-
sis  greater  or  equal  to  50%  on  MSCT-CA  were  admitted  to  the
cardiology  unit  and  had  ICA.  Qualitative  ICA  was  performed
by  one  of  the  nine  physicians  from  the  catheterization  lab-
oratory  of  the  University  Hospital  of  Rangueil  in  Toulouse.
The  interventional  cardiologist  was  aware  of  the  results
of  the  MSCT-CA.  The  ICA  was  visually  interpreted  by  two
observers.  Automated  analysis  stenosis  severity  assessment
was  also  applied  for  lesions  greater  or  equal  to  50%,  with  an
automated  edge-detection  system  (Medical  QCA/CMS;  Medis
Imaging  System,  Leiden,  The  Netherlands).  A  functional
stress  test  (myocardial  perfusion  imaging,  stress  echocardio-
graphy  or  exercise  treadmill  test,  according  to  availability)
or  fractional  ﬂow  reserve  (FFR)  was  performed  to  assess  the
haemodynamic  signiﬁcance  of  intermediate  stenosis  greater
or  equal  to  50%  but  less  or  equal  to  70%  and  direct  myocar-
dial  revascularization  indication.  Only  Lesions  with  an  FFR
less  than  0.80  at  maximum  hyperaemia  were  considered
functionally  signiﬁcant  and  were  treated  by  mechanical
revascularization  [18]. Only  severe  lesions  and  intermediate
lesions  with  proven  myocardial  ischaemia  were  considered
for  myocardial  revascularization.  Non-obstructive  CAD  is
deﬁned  by  stenosis  greater  or  equal  to  50%  but  less  or  equal
to  70%  on  ICA  with  a  negative  stress  test  or  FFR  test.  Medi-
cal  therapy,  including  aspirin,  beta-blockers  and  statins,  was
proposed  for  patients  with  non-obstructive  CAD.  Obstructive
CAD  is  deﬁned  by  stenosis  greater  or  equal  to  70%  on  ICA  or
less  or  equal  to  50%  on  ICA  with  an  abnormal  functional  stress
test  or  FFR  less  than  0.80.  A  revascularization  strategy  asso-
ciated  with  medical  therapy  was  proposed  for  obstructive
CAD  patients.
Follow-up
All  patients  or  proxies  and  general  practitioners  were  con-
tacted  by  the  ﬁrst  investigator  (S.H.)  by  a  telephone  recall
between  January  2010  and  April  2011.  Clinical  status  was
queried.  During  follow-up,  death  or  a  history  of  myocar-
dial  infarction,  myocardial  revascularization  or  heart  failure
was  searched  for.  The  main  outcome  criteria  were  major
adverse  coronary  events  (MACE),  deﬁned  as  myocardial
infarction,  myocardial  revascularization  and  cardiovascular
death  occurring  after  the  primary  hospitalization.  For  the
patients  followed  in  our  cardiology  department,  the  follow-
up  data  in  the  medical  information  ﬁle  were  noted.Statistical analysis
Continuous  variables  are  expressed  as  mean  ±  standard  devi-
ation  (SD)  and  the  median  is  provided  if  the  distribution
m
M
n
i341
f  the  variable  departed  from  normality.  Categorical  varia-
les  are  expressed  as  total  number  (percentage).  The  SCORE
ethod  with  continuity  correction  was  used  to  estimate  the
5%  conﬁdence  interval  (CI)  for  proportions  [19]. Student’s  t
est  was  performed  to  compare  means  of  quantitative  varia-
les  between  groups.  Fisher’s  exact  test  was  performed  to
ompare  proportions.  A  p  value  less  than  0.05  was  con-
idered  to  be  statistically  signiﬁcant.  All  calculations  were
one  using  MedCalc  statistical  software,  version  8.0  (Med-
alc  Software,  Mariakerke,  Belgium).
esults
 total  of  123  patients  constituted  our  ﬁnal  population.
tudy  population  characteristics  are  listed  in  Table  1.  Preva-
ence  of  CAD  and  patient  course  are  presented  in  Fig.  1.
n  two  cases  (1.63%),  MSCT-CA  analysis  was  not  possible
ecause  of  kinetic  artefacts  due  to  high  heart  rate.  Of  these
wo  patients,  one  had  a  negative  stress  echocardiography
nd  was  discharged  without  MACE  during  a  median  15-month
ollow-up.  The  other  patient  had  ICA  that  revealed  signiﬁ-
ant  stenosis  of  the  left  anterior  descending  artery  and  had
yocardial  revascularization  by  angioplasty  and  one  stent.
ccording  to  MSCT-CA  results,  93  patients  (75.6%)  had  no
r  mild  CAD  and  28  patients  (22.8%)  had  stenosis  greater  or
qual  to  50%.  ICA  was  performed  in  29  patients  (23.6%).  A
omplementary  diagnostic  functional  stress  test  or  FFR  was
ecessary  in  20  patients.  A  negative  FFR  was  measured  in
hree  patients.  Obstructive  CAD  requiring  myocardial  revas-
ularization  was  diagnosed  in  10  patients  (8.13%).  Stenosis
reater  or  equal  to  70%  was  observed  in  nine  patients;  one
atient  had  stenosis  between  50%  and  70%  and  a  positive
tress  echocardiography.  Of  these  10  patients,  eight  were
t  low  risk  and  two  were  at  intermediate  risk.  Of  the  28
atients  with  stenosis  greater  or  equal  to  50%  on  MSCT-CA,
9  patients  had  stenosis  less  or  equal  to  70%  on  ICA  and  a
egative  FFR/functional  stress  test  and  were  classiﬁed  as
aving  non-obstructive  CAD.  Patient  characteristics  accord-
ng  to  CAD  severity  are  listed  in  Table  1.  In  Table  2,  patients
nally  diagnosed  with  obstructive  CAD  are  compared  with
he  remaining  sample  (i.e.  patients  with  no  or  mild  CAD
ccording  to  MSCT-CA  results  and  those  with  MSCT-CA  steno-
is  greater  or  equal  to  50%  but  without  obstructive  CAD
ccording  to  ICA  and  FFR/functional  stress  test).  Chest  pain
hought  to  be  typical  angina  pectoris  was  a  factor  signiﬁ-
antly  associated  with  obstructive  CAD  according  to  Fisher’s
xact  test  (p  =  0.0449).  Mean  age  was  higher  in  patients
ith  obstructive  CAD  (p  =  0.0476).  The  probability  of  having
bstructive  CAD  after  a  positive  MSCT-CA  was  35.7%.
The  mean  estimated  effective  dose  of  MSCT-CA  was
6.3  ±  6.4  mSv  (3.0—33.7  mSv).  Mean  radiation  exposure  was
igher  in  young  people  (p  =  0.024),  patients  with  a high  BMI
p  =  0.0386)  and  men  (p  =  0.045).  No  acute  renal  insufﬁciency
r  beta-blocker  side-effects  were  reported.
Median  follow-up  was  15  (7—30)  months.  Follow-up  data
ere  available  for  every  patient.  No  patient  (95%  CI  0—3.0%)
ad  MACE  during  follow-up.  Of  the  10  patients  who  had
yocardial  revascularization  at  the  ﬁrst  step,  none  had
ACE  during  follow-up.  Of  the  93  patients  who  had  a
egative  MSCT-CA,  none  (95%  CI  0—5.0%)  had  MACE  dur-
ng  follow-up.  The  negative  predictive  value  of  MSCT-CA
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Table  1  Patient  characteristics.
Variable  All  patients
(n =  123)
MSCT-CA  ICA  ±  FFR/stress  test
No  CADa
(n  =  66)
Mild  CAD
(n  =  27)
Stenosis  ≥  50%
(n  =  29)b
Non-obstructive  stenosis
(n  =  19)
Obstructive  stenosis
(n  =  10)
Age  (years)  50.9  ±  13.8  (19—86)  47.6  ±  13.0  52.3  ±  12.8  57.3  ±  13.0  56.5  ±  13.6  58.8  ±  12.4
Men  87  (70.4)  44  (66.7)  19  (70.4)  24  (82.8)  15  (79.0)  9  (90.0)
Weight  (kg)  74.5  ±  13.8
Body  mass  index  25.2  ±  4.2
Cardiac  risk  factors
Hypertension  41  (33.3)  18  (27.3)  10  (37.0)  12  (41.4)  8  (42.1)  5  (50.0)
Hypercholesterolaemia  46  (37.4)  21  (31.8)  11  (40.7)  13  (44.8)  8  (42.1)  5  (50.0)
Current  or  former  smoker  68  (55.3)  37  (56.1)  14  (51.9)  17  (58.6)  11  (57.9)  6  (60.0)
Diabetes  mellitus  16  (13.0)  7  (10.6)  2  (7.4)  6  (20.7)  4  (21.1)  2  (20.0)
Family  history  of  CAD  39  (31.7)  21  (31.8)  10  (37.0)  6  (20.7)  4  (21.1)  2  (20.0)
Men  aged  >  50  years  or  49  (39.9)  18  (27.2)  13  (48.1)  18  (62.1)  12  (63.2)  6  (60.0)
Women  aged  >  60  years
Risk  factors
None  11  (8.9)  8  (12.1)  1  (3.7)  2  (6.9)  2  (10.5)  0  (0.0)
1  24  (19.5)  16  (24.2)  4  (14.8)  4  (13.8)  2  (10.5)  2  (20.0)
2  49  (39.9)  26  (39.4)  13  (48.1)  10  (34.5)  7  (36.8)  3  (30.0)
≥  3  39  (31.7)  16  (24.2)  9  (33.4)  13  (44.8)  8  (42.1)  5  (50.0)
Symptoms
Atypical  chest  pain  51  (41.5)  30  (45.5)  11  (40.7)  9  (31.0)  8  (42.1)  1  (10.0)
Typical  angina  pectoris  72  (58.5)  36  (54.5)  16  (59.3)  20  (69.0)  11  (57.9)  9  (90.0)
TIMI  score
0  72  (58.5)  40  (60.6)  19  (70.4)  13  (44.8)  8  (42.1)  5  (50.0)
1  41  (33.3)  22  (33.3)  6  (22.2)  12  (41.1)  8  (42.1)  4  (40.0)
2  10  (8.1)  4  (6.1)  2  (7.4)  4  (13.8)  3  (15.8)  1  (10.0)
Median  0
Range  0—2
GRACE  score
Low  risk:  ≤  88  108  (87.8)  61  (82.4)  24  (88.9)  22  (75.9)  14  (73.7)  8  (80.0)
Intermediate  risk:  89—118  15  (12.2)  5  (7.6)  3  (11.1)  7  (24.1)  5  (26.3)  2  (20.0)
Median  52
Range  18—111
Radiation  dose  (mSv)  16.3  ±  6.3  (3.0—33.7)
Data are mean ± standard deviation (min—max) or number (%). CAD: coronary artery disease; FFR: fractional ﬂow reserve; GRACE: Global Registry of Acute Cardiac Events; ICA: invasive
coronary angiography; MSCT-CA: multislice computed tomography coronary angiography; TIMI: Thrombolysis in Myocardial Infarction.
a Absence of CAD on MSCT-CA.
b The patient with non-diagnostic MSCT-CA but obstructive stenosis on ICA was counted in this group.
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for  MACE  occurrence  during  follow-up  was  100%  (95%  CI
95—100%).
Discussion
In  the  present  study,  MSCT-CA  identiﬁed  ten  patients  (8.13%)
with  obstructive  CAD  requiring  myocardial  revascularization
from  a  sample  of  123  patients  with  acute  chest  pain  at  low-
to-intermediate  risk  presenting  to  an  ED.  These  ten  patients
had  a  low  TIMI  risk  score  (between  0  and  2)  and  eight  patients
(80%)  had  a  low  GRACE  risk  score.  These  results  conﬁrm  the
need  for  further  testing  in  low-risk  chest  pain  patients  and
the  value  of  MSCT-CA.
Furthermore,  75.6%  of  patients  with  acute  chest  pain
had  no  CAD  or  coronary  artery  lesions  less  or  equal  to  50%
on  MSCT-CA  and  did  not  have  an  adverse  coronary  event
or  death  (95%  CI  0—3%)  during  a  median  follow-up  of  15
months.  Our  results  correspond  with  those  reported  by  Hol-
lander  et  al.  in  the  USA  and  Schlett  et  al.  in  Germany  [20,21].
Negative  MSCT-CA  could  therefore  allow  immediate  and  safe
dismissal  from  the  ED  of  these  patients  with  acute  chest
pain  without  ECG  abnormalities  or  a  rise  in  serum  cardiac
biomarkers.  Given  the  large  number  of  such  patients,  early
MSCT-CA  may  signiﬁcantly  improve  patient  management  in
the  ED.
MSCT-CA  offers  direct  visualization  of  the  coronary  arter-
ies  but  does  not  provide  information  on  inducible  ischemia.
As  we  did  not  perform  a  stress  test  systematically,  we  can-
not  compare  our  results  with  another  diagnostic  strategy
based  on  a  stress  test.  In  our  institution,  stress  tests  such  as
p
5
t
ltress  echocardiography,  nuclear  myocardial  perfusion  imag-
ng,  magnetic  resonance  imaging  and  the  standard  treadmill
est  are  not  available  24  hours/day.  Conversely,  MSCT-CA  is
vailable  quickly.  The  feasibility  of  MSCT-CA  in  the  ED  is  not
urrently  applicable  in  all  centres  24  hours/day.  However,
ur  results  conﬁrm  that  further  testing  in  low-risk  chest  pain
atients  is  necessary.  According  to  previous  studies,  a  diag-
ostic  strategy  with  MSCT-CA  could  shorten  the  length  of
tay,  decrease  costs,  reduce  the  need  for  ICA  and  improve
rognosis  compared  with  chest  pain  unit  management  with
CA  or  the  stress  tests  in  use  at  the  moment  [22—25]. Given
ur  results  and  these  studies,  MSCT-CA  may  be  one  of  the
rst  triage  examinations  that  should  be  widely  available
4  hours/day,  particularly  in  small  centres.
The  probability  of  having  obstructive  CAD  in  the  pres-
nce  of  coronary  artery  stenosis  greater  or  equal  to  50%
n  MSCT-CA  is  only  35.7%.  The  clinical  impact  of  a  posi-
ive  result  is  limited  and  may  require  additional  non-invasive
nvestigation  before  ICA.  Patients  with  acute  chest  pain
nd  coronary  artery  stenosis  greater  or  equal  to  50%  on
SCT-CA  but  without  haemodynamic  signiﬁcance  on  FFR  or
unctional  stress  test  seemed  to  have  no  coronary  event  or
eath  under  medical  treatment.  This  sample  of  patients  was
ow  (n  =  18,  15%).  This  observation  is  in  agreement  with  the
esults  of  Pijls  et  al.  [26]. Given  these  results,  we  would
ecommend  performing  a  functional  test  without  radiation,
uch  as  stress  echocardiography,  when  MSCT-CA  suggests  the
resence  of  coronary  artery  stenosis  greater  or  equal  to
0%,  reserving  ICA  for  a  positive  or  inconclusive  functional
est  result.  For  patients  in  whom  MSCT-CA  suggests  severe
esions,  ICA  may  be  required  to  conﬁrm  the  anatomy  of  the
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Table  2  Risk  markers  of  obstructive  coronary  artery  disease.
Characteristic  No,  mild  or  non-obstructive  CAD
(n  =  113)
Obstructive  CAD
(n  =  10)
Odds  ratio  (95%  CI)  p
Smokers 62  (54.9)  6  (60.0)  1.24  (0.33—4.61)  1.00
Diabetes  14  (12.4)  2  (20.0)  1.77  (0.34—9.18)  0.62
Hypercholesterolaemia  41  (36.3)  5  (50.0)  1.75  (0.48—6.43)  0.50
Hypertension  36  (31.9)  5  (50.0)  2.14  (0.58—7.86)  0.30
Family  history  of  CAD 37  (32.7) 2  (20.0) 0.51  (0.10—2.54)  0.50
≥  3  risk  factors 34  (30.1) 5  (50.0) 2.32 (0.63—8.55)  0.29
Typical  angina  pectoris 63  (55.8) 9  (90.0) 7.14 (0.88—58.28) 0.0449a
GRACE  score  ≥  88 13  (11.5) 2  (20.0) 2.12 (0.41—11.05) 0.35
TIMI  score  =  2  9  (8.0)  1  (10.0)  1.28  (0.15—11.31)  0.59
Men  78  (69.0)  9  (90.0)  4.04  (0.50—33.12)  0.28
Men  aged  ≥  50  years  or
women  aged  ≥  60
years
43 (38.1)  6  (60.0)  2.44  (0.65—9.15)  0.19
Age  (years)  50  ±  13.4  58.8  ±  12.4  0.0476a
CAD: coronary artery disease; CI: conﬁdence interval; GRACE: Global Registry of Acute Cardiac Events; TIMI: Thrombolysis in Myocardial
Infarction.
Data are mean ± standard deviation or number (%).
a Student’s t test was performed to compare mean age; Fisher’s exact test was performed to compare proportions.
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iesions  detected.  In  these  cases,  in  our  experience,  FFR  pro-
ides  a  fast  assessment  of  the  haemodynamic  signiﬁcance
f  the  ambiguous  lesions  during  the  same  examination  and
mproves  the  myocardial  revascularization  indication  deci-
ion.  Fortuitous  discoveries  of  non-obstructive  CAD  will  also
llow  early  risk  factor  modiﬁcation,  thereby  potentially  pre-
enting  future  cardiac  events.  But  the  relevance  of  this
pproach  needs  to  be  evaluated  in  large  dedicated  studies
3].
There  was  variety  in  the  patients’  ages  (19  to  86  years)
nd  levels  of  risk  (very  low  risk  to  intermediate  risk).  The
tudy  population  represented  only  a  sample  of  all  patients
resenting  to  the  ED  with  chest  pain.  This  makes  it  dif-
cult  to  deﬁne  the  cohort  of  patients  that  is  best  suited
o  this  new  technology.  We  excluded  patients  at  high  risk
nd  patients  with  known  CAD,  thereby  limiting  applicability
or  many  ED  patients;  but  MSCT-CA  does  not  improve  risk
tratiﬁcation  and  early  ICA  is  recommended  [1,27]. We  also
xcluded  patients  with  contraindications  to  MSCT-CA.  But  it
eems  that  approximately  80%  of  non-CAD  patients  under-
oing  a  rule-out  ACS  process  could  be  suitable  for  MSCT-CA
28].  Almost  one-quarter  of  these  are  from  very  low-risk
roups  and  the  risk/cost-beneﬁt  ratio  of  further  testing  is
ubious.  We  identiﬁed  two  main  factors  that  could  improve
he  pretest  probability  of  having  obstructive  CAD:  older  age
nd  typical  angina-like  symptoms.  Therefore,  in  a  setting
f  a  low-risk  young  patient  with  highly  atypical  symptoms,
o  additional  diagnostic  evaluation  may  be  required.  The
ecent  recommendations  of  the  National  Institute  for  Health
nd  Clinical  Excellence  in  the  UK  proposed  that  the  indi-
ation  for  MSCT-CA  in  ACS  at  low  risk  should  therefore  be
ased  on  the  pretest  prevalence  of  CAD,  according  to  age,
ex,  cardiovascular  risk  factors  and  chest  pain  characteris-
ics  [3].  The  results  of  our  study  conﬁrm  the  merits  of  these
ew  recommendations.
i
r
t
aA signiﬁcant  issue  with  MSCT-CA  is  radiation  exposure.
ean  estimated  effective  dose  is  high  (estimated  as  16.3
Sv)  despite  appropriate  image  acquisition  protocol.  Guéret
t  al.  reported  a  higher  mean  exposure  of  19  mSv  in  a  French
ulticentre  observational  study  carried  out  at  the  same  time
29].  Chow  et  al.  reported  a  similar  estimated  effective
ose  of  15  mSv  in  a  similar  sample  of  patients  with  acute
hest  pain  in  an  ED  in  an  experimental  centre  in  Canada
30]. Little  is  still  known  about  the  long-term  effects  of
adiation.  An  increasing  risk  of  cancer  is  suspected  above
0  mSv  [31].
onclusion
SCT-CA  is  a  promising  technology  for  chest  pain  evaluation
n  the  ED.  Our  results  suggest  that  it  could  be  a  useful  and
ecessary  initial  triage  tool.  When  the  MSCT-CA  result  is  neg-
tive,  it  allows  safe  and  early  discharge  because  of  its  high
egative  predictive  value.  In  a  signiﬁcant  number  of  low-risk
CS  patients,  MSCT-CA  detects  severe  coronary  lesions  and
llows  dedicated  further  diagnostic  and  therapeutic  inter-
ention.  Some  people  suggest  that  it  should  be  a  ﬁrst-line
est  [32]. Our  results  are  a  validation  of  the  French  recom-
endations  published  in  2009  [15]. New  guidelines  from  the
uropean  Society  of  Cardiology  for  the  management  of  ACS
ow  recommend  (with  a  class  IIa)  the  use  of  MSCT-CA  as  an
lternative  to  ICA  to  exclude  ACS  when  there  is  a  low-to-
ntermediate  likelihood  of  CAD  and  when  troponin  and  ECG
re  inconclusive  [33]. But  the  inability  of  anatomical  ﬁnd-
ngs  to  prove  the  presence  of  ischaemia  and  the  cancer  risk
nduced  by  radiation  exposure  still  raise  concerns  about  the
elevance  of  this  strategy.  The  results  of  our  study  deserve
o  be  completed  by  multicentre  analysis  and  compared  with
 diagnosis  strategy  based  on  a  stress  test  alone.
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